TGFB1 and diabetic kidney disease: Tranilast, a membrane-stabilizing agent of mast cells used for treating bronchial asthma, suppresses collagen synthesis in early and advanced diabetic nephropathy by interfering with the actions of TGFβ1 [34,35].